Investigating the Efficacy of EGFR-TKIs and Anti-VEGFR Combination in Advanced Non-Small Cell Lung Cancer: A Meta-Analysis.

Prashant SakharkarSonali KurupSubrata DebKaitlin AssaadDayna GesinskiErysa J Gayle

Published in: Cancers (2024)

Our meta-analysis indicated EGFR-TKIs with anti-VEGFR in combination not only improved overall PFS but also showed similar results to a first line and first-generation agent compared to EGFR-TKI alone.

Keyphrases

epidermal growth factor receptor
advanced non small cell lung cancer
tyrosine kinase
small cell lung cancer
systematic review
vascular endothelial growth factor
meta analyses
randomized controlled trial